Objective: Odontogenic cyst surgeries are commonly performed procedures, but they may present challenges with
wound healing during the postoperative period. However, insufficient research exists on this topic. This study aimed
to determine the risk factors linked to incomplete wound healing after removing a benign odontogenic cyst in the
maxilla.
Methods: This study involved patients who underwent transoral Caldwell–Luc surgery and endoscopic endonasal
surgery to treat benign odontogenic cysts located in the maxilla between 2014 and 2024 at the University Hospital.
Investigated risk factors included demographic factors (gender, age), medical history (comorbidities, smoking habits),
cyst size, and serum inflammatory markers like neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio,
and systemic immune-inflammation index (SII). After 3 months of the postoperative period, patients were classified
as either having incomplete or optimal healing.
Results: Smoking affected incomplete wound healing (χ² = 6.09, P = .0136). Large cysts are associated with the devel-
opment of poor healing (odds ratio (OR) = 7.5, 95% confidence interval (CI) 1.20 to 47.05, P = .0473). Also, high NLR and
SII levels were found to be essential factors in suboptimal wound healing (OR = 4.667, 95% CI 0.42 to 52.12, P = .294;
OR = 9.1, 95% CI 1.39 to 59.62, P = .037, respectively).
Conclusion: This study emphasized the significance of assessing cyst size, smoking status, and inflammatory met-
rics like serum NLR and SII before benign odontogenic cyst surgeries. Neutrophil-to-lymphocyte ratio and SII, easily
obtained from routine serum tests, may serve as cost-effective prognostic values for wound healing, replacing expen-
sive immunological biomarkers.
Biomarkers immune system lymphocytes maxillo-mandibular surgery neutrophils odontogenic cysts platelets smoking wound healing
| Primary Language | English |
|---|---|
| Subjects | Otorhinolaryngology |
| Journal Section | Research Article |
| Authors | |
| Submission Date | August 12, 2024 |
| Acceptance Date | October 13, 2024 |
| Publication Date | December 10, 2024 |
| Published in Issue | Year 2024 Volume: 7 Issue: 3 |
You can find the current version of the Instructions to Authors at: https://www.eurjrhinol.org/en/instructions-to-authors-104
Starting on 2020, all content published in the journal is licensed under the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International
License which allows third parties to use the content for non-commercial purposes as long as they give credit to the original work. This license
allows for the content to be shared and adapted for non-commercial purposes, promoting the dissemination and use of the research published in
the journal.
The content published before 2020 was licensed under a traditional copyright, but the archive is still available for free access.